Sangamo Therapeutics, Inc financial data

Symbol
SGMO on Nasdaq
Location
501 Canal Blvd., Richmond, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 106 % -47%
Debt-to-equity 359 % +247%
Return On Equity -40.4 % +10.5%
Return On Assets -63.9 % +61.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 302M shares +44.9%
Common Stock, Shares, Outstanding 213M shares +19.5%
Entity Public Float 74.2M USD -67.6%
Common Stock, Value, Issued 2.73M USD +31%
Weighted Average Number of Shares Outstanding, Basic 257M shares +26%
Weighted Average Number of Shares Outstanding, Diluted 257M shares +26%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 81.7M USD +566%
Research and Development Expense 104M USD -37.8%
General and Administrative Expense 40.1M USD -21.2%
Operating Income (Loss) -62.8M USD +75.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63.5M USD +74.4%
Income Tax Expense (Benefit) -193K USD -116%
Net Income (Loss) Attributable to Parent -63.3M USD +74.6%
Earnings Per Share, Basic 0 USD/shares +81.4%
Earnings Per Share, Diluted 0 USD/shares +81.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.3M USD +38%
Cash, Cash Equivalents, and Short-term Investments 81M USD -73.7%
Accounts Receivable, after Allowance for Credit Loss, Current 372K USD -36%
Assets, Current 49.9M USD +24.5%
Property, Plant and Equipment, Net 15.7M USD -23.7%
Operating Lease, Right-of-Use Asset 15.1M USD -19.3%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 0 USD
Other Assets, Noncurrent 890K USD
Assets 97.6M USD +4.89%
Accounts Payable, Current 10.7M USD -38.9%
Accrued Liabilities, Current 13.9M USD -11.6%
Contract with Customer, Liability, Current 7.56M USD
Liabilities, Current 47.7M USD +22.2%
Contract with Customer, Liability, Noncurrent 5.87M USD
Deferred Income Tax Liabilities, Net 15K USD
Operating Lease, Liability, Noncurrent 23.5M USD -19.4%
Other Liabilities, Noncurrent 962K USD -21.3%
Liabilities 78M USD +12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.46M USD +75.2%
Retained Earnings (Accumulated Deficit) -1.55B USD -4.24%
Stockholders' Equity Attributable to Parent 19.6M USD -17.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 82.9M USD -71.9%
Liabilities and Equity 97.6M USD +4.89%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26.1M USD +46.3%
Net Cash Provided by (Used in) Financing Activities 8.13M USD -63.2%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 960M shares 0%
Common Stock, Shares, Issued 213M shares +19.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.7M USD -294%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 39.8M USD +43.4%
Deferred Tax Assets, Valuation Allowance 368M USD +4.6%
Deferred Tax Assets, Gross 371M USD +3.94%
Operating Lease, Liability 30.6M USD -19.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58.9M USD +76.4%
Lessee, Operating Lease, Liability, to be Paid 37M USD -18.2%
Property, Plant and Equipment, Gross 57.7M USD -25.9%
Operating Lease, Liability, Current 4.31M USD -6.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.37M USD -2.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.71M USD -1.74%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +35.7%
Deferred Income Tax Expense (Benefit) 15K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.21M USD -9.77%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.32M USD -2.91%
Deferred Tax Assets, Operating Loss Carryforwards 212M USD +7.56%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 22.1M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.5M USD +0.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.02M USD -27.5%
Deferred Tax Assets, Net of Valuation Allowance 3.68M USD -36.2%
Share-based Payment Arrangement, Expense 11.4M USD -36.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%